Journal article
High prevalence of elevated molybdenum levels in pediatric CKD patients. A cross-sectional and longitudinal study.
Abstract
AIMS: Many of the secondary effects of high levels of molybdenum (Mo) overlap with symptoms commonly seen in pediatric patients with chronic kidney disease (CKD). We measured plasma Mo levels and examined the relationship between Mo levels and kidney function.
MATERIALS AND METHODS: The study was carried out at the London Health Sciences Centre in London, Ontario, Canada with 36 children and adolescents 4 - 18 years of age with CKD. There were …
Authors
Filler G; Belostotsky V; Kobrzynski M; Huang S-HS; Yang L
Journal
Clinical Nephrology, Vol. 88, No. 8, pp. 79–85
Publisher
Dustri-Verlag Dr. Karl Feistle
Publication Date
August 1, 2017
DOI
10.5414/cn109015
ISSN
0301-0430